Active ingredient
Bumetanide
129 finished FDA listings contain Bumetanide as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- BUMETANIDE
- Dosage forms
- Injection, Injection, Solution, Spray, Tablet
- Routes
- Intramuscular, Intravenous, Nasal, Oral
- Manufacturers / labelers
- 41
- Strengths listed
- .25 mg/ml · .5 mg/.1ml · .5 mg/1 · 1 mg/1 · 2 mg/1
- Brand names in FDA listings
- Bumex, Enbumyst
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1808
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 018225 | VALIDUS PHARMS | 1983-02-28 | 8 |
| ANDA 074441 | SAGENT | 1995-01-27 | 3 |
| ANDA 074225 | HERITAGE PHARMA | 1995-04-24 | 6 |
| ANDA 074700 | SANDOZ | 1996-11-21 | 20 |
| ANDA 079196 | WEST-WARD PHARMS INT | 2008-04-30 | 8 |
| ANDA 209724 | AMNEAL PHARMS CO | 2017-10-18 | 12 |
| ANDA 209916 | UPSHER SMITH LABS | 2018-01-23 | 4 |
| ANDA 202900 | ZYDUS PHARMS | 2018-04-30 | 9 |
| ANDA 212019 | RISING | 2019-12-12 | 4 |
| ANDA 216434 | GLAND | 2022-05-26 | 6 |
| ANDA 215364 | MSN | 2022-08-04 | 5 |
| ANDA 213458 | TARO | 2023-07-24 | 3 |
| ANDA 217153 | LUPIN | 2024-09-17 | 1 |
| ANDA 212931 | APPCO | 2024-09-18 | 8 |
| ANDA 219116 | QILU PHARM HAINAN | 2024-09-19 | 4 |
| ANDA 213942 | RUBICON RESEARCH | 2024-12-27 | 12 |
| ANDA 218746 | ASPIRO | 2025-02-27 | 2 |
| ANDA 219291 | MANKIND PHARMA | 2025-04-03 | 8 |
| NDA 219500 | CORSTASIS THERAP | 2025-09-12 | 1 |
| ANDA 215362 | MSN | 2026-02-05 | 3 |
| ANDA 220427 | ADAPTIS | 2026-02-26 | 2 |
Official labeling on DailyMed
- BUMETANIDE TABLET [REMEDYREPACK INC.] · version 3 · 2026-09-10
- BUMETANIDE TABLET [REMEDYREPACK INC.] · version 2 · 2026-09-10
- ENBUMYST (BUMETANIDE) SPRAY [CORSTASIS USA LLC] · version 4 · 2026-08-31
- BUMETANIDE TABLET [NORTHSTAR RX LLC] · version 4 · 2026-08-24
- BUMETANIDE TABLET [MAJOR PHARMACEUTICALS] · version 7 · 2026-08-20
- BUMETANIDE INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] · version 6 · 2026-08-10
- BUMETANIDE INJECTION, SOLUTION [CIVICA, INC.] · version 1 · 2026-08-03
- BUMETANIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] · version 2 · 2026-08-03
- BUMETANIDE INJECTION [CARDINAL HEALTH 107, LLC] · version 1 · 2026-07-07
- BUMETANIDE INJECTION, SOLUTION [ANTHEA PHARMA PRIVATE LIMITED] · version 5 · 2026-07-02
- BUMETANIDE TABLET [SANDOZ INC] · version 1 · 2026-06-19
- BUMETANIDE TABLET [A-S MEDICATION SOLUTIONS] · version 1 · 2026-05-20
Showing the 12 most recent of 73 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.